retatrutide diabetes Phase 2: Type 2 Weight Loss and Key Trial Findings – Bolt Pharmacy Retatrutide — A Breakthrough in

The startup, which focuses on psychology-driven weight loss with behavior coaching, last raised $540 million in Series F funding in 2021 at a $3.7 billion valuation

It offers high purity for consistent results and comes lyophilized for improved stability and easier storage and reconstitution

It's effective at reducing appetite in the short term, and for some patients produces meaningful early weight loss

A study extension also found that people with a starting BMI of 35 or above who continued treatment to 104 weeks lost up to an average of 30.3% of their body weight

Our compassionate care and unlimited support ensure that you have guidance every step of the way, helping you understand and navigate any potential side effects